D. E. Shaw & Co., Inc. AMAG PHARMACEUTICALS INC Transaction History

D. E. Shaw & Co., Inc.

  • $107 Billion
  • Q3 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
N/A
-1,093,639 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
N/A
115,293 Added 11.78%
1,093,639 $10.3 Million
Q2 2020

Aug 14, 2020
SELL
N/A
-4,300 Reduced 0.44%
978,346 $7.49 Million
Q1 2020

May 15, 2020
SELL
N/A
-7,907 Reduced 0.8%
982,646 $6.07 Million
Q4 2019

Feb 14, 2020
SELL
N/A
-5,500 Reduced 0.55%
990,553 $12.1 Million
Q3 2019

Nov 14, 2019
SELL
N/A
-26,001 Reduced 2.54%
996,053 $11.5 Million
Q2 2019

Aug 14, 2019
SELL
N/A
-15,705 Reduced 1.51%
1,022,054 $10.2 Million
Q1 2019

May 15, 2019
BUY
N/A
2,966 Added 0.29%
1,037,759 $13.4 Million
Q4 2018

Feb 14, 2019
SELL
N/A
-13,856 Reduced 1.32%
1,034,793 $15.7 Million
Q3 2018

Nov 14, 2018
BUY
N/A
37,122 Added 3.67%
1,048,649 $21 Million
Q2 2018

Aug 14, 2018
BUY
N/A
117,306 Added 13.12%
1,011,527 $19.7 Million
Q1 2018

May 15, 2018
SELL
N/A
-73,494 Reduced 7.59%
894,221 $18 Million
Q4 2017

Feb 14, 2018
SELL
N/A
-219,468 Reduced 18.49%
967,715 $12.8 Million
Q3 2017

Nov 14, 2017
BUY
N/A
1,187,183
1,187,183 $21.9 Million
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email